New drugs: dabigatran etexilate mesylate, fingolimod hydrochloride, and ulipristal acetate.
Philadelphia College of Pharmacy, University of the Sciences in Philadelphia, Philadelphia, PA, USA.
Daniel A
DA
Hussar
David E
DE
Zimmerman
D000925:Anticoagulants / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D003283:Contraceptives, Postcoital, Synthetic / Q000009:adverse effects / Q000627:therapeutic use*; D000069604:Dabigatran; D005260:Female; D000068876:Fingolimod Hydrochloride; D006801:Humans; D008297:Male; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy*; D009649:Norpregnadienes / Q000009:adverse effects / Q000627:therapeutic use*; D011409:Propylene Glycols / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D011725:Pyridines / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D013110:Sphingosine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D020246:Venous Thrombosis / Q000188:drug therapy / Q000517:prevention & control
D000925:Anticoagulants; D001562:Benzimidazoles; D003283:Contraceptives, Postcoital, Synthetic; D009649:Norpregnadienes; D011409:Propylene Glycols; D011725:Pyridines; D000068876:Fingolimod Hydrochloride; D000069604:Dabigatran; D013110:Sphingosine; C555622:ulipristal acetate